Breast Cancer Sequencing Study Finds Many Metastatic Mutations are Undetectable in Primary Tumor | GenomeWeb

By Julia Karow

This article, originally published Oct.7, has been updated with comments from an author of the study.

A primary breast cancer acquired several new mutations in its protein-coding regions as it progressed toward metastasis, according to a new report by Canadian researchers, who argue that studying these mutations might help scientists understand why cancers become treatment resistant.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.